ArchivesMagazine - 23 Jul 2020Biotech rally on Covid treatments becoming harder to justify Investors appear to be pricing in significant future financial rewards which may ultimately disappoint 23 July 2020|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Stamp duty holiday boosts house prices and property-related shares Tech stock mania: everyone wants a slice of the digital world > Issue: 23 Jul 2020 - Page 6 | Contents Next: Tech stock mania: everyone wants a slice of the digital world Previous: Stamp duty holiday boosts house prices and property-related shares Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom Can I get pension tax relief from abroad? Editor's View Predicting investment returns for the next decade Feature 20 small caps where analysts are upgrading earnings forecasts The reasons why inflation could make a comeback Tech stock mania: everyone wants a slice of the digital world First-time Investor Does broker research add value and how can I access it? Funds Lesser-known quality funds giving Fundsmith a run for its money Great Ideas Tune into Focusrite for big growth potential The stock thriving from a boom in alternatives and ESG investments Forecast beat a good start for Gamma Communications ASML up 30% in three months, but more to come Begbies hikes dividend after solid year Investment Trusts The investment trusts trading at larger than usual discounts and premiums News Biotech rally on Covid treatments becoming harder to justify Netflix under pressure to retain customers won during lockdown Stamp duty holiday boosts house prices and property-related shares Future shows resilience to coronavirus crisis UK dividends could drop by 40% in 2020 Personal Finance How to beat the potential capital gains tax hike Russ Mould The 20 names which hold the key to UK dividends
